European heart group issues guidelines on 4 new anticoagulants

05/3/2013 | TheHeart.org (Montreal) (free registration)

The European Heart Rhythm Association of the European Society of Cardiology has released practice guidelines for the use of the oral anticoagulants dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation. The guide includes clinical scenarios and information on managing bleeding risks.

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA